SMTL ID : 8uky.1 (1 other biounit)

Crystal structure of BAK in complex with inhibiting antibody 14G6

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 4 residues within 4Å: Chain A: W.50, S.52 Chain C: E.16, R.140 4 PLIP interactions: 3 interactions with chain A, 1 interactions with chain C Hydrogen bonds: A:W.50, A:S.52 Water bridges: A:S.52 Salt bridges: C:R.140

3 x CCN: ACETONITRILE(Non-functional Binders)

CCN.2: 2 residues within 4Å: Chain A: S.207, N.209 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.209 CCN.4: 7 residues within 4Å: Chain A: R.95, T.96, F.97 Chain B: L.45, E.46, W.47, N.61 3 PLIP interactions: 2 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:T.96, B:W.47 Hydrogen bonds: A:F.97 CCN.5: 6 residues within 4Å: Chain A: D.166, D.169 Chain B: T.165, G.167, V.168, H.169 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:G.167

3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.3: 5 residues within 4Å: Chain A: Q.37, K.45, F.62, E.81, D.82 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.37, A:E.81 PEG.6: 6 residues within 4Å: Chain A: T.163, E.164, D.166 Chain B: V.168, H.169, T.170 3 PLIP interactions: 2 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:T.170 Water bridges: B:H.169, A:T.171 PEG.7: 7 residues within 4Å: Chain B: Y.32, L.101, Y.102 Chain C: R.20, F.24, H.27, Q.31 4 PLIP interactions: 2 interactions with chain B, 2 interactions with chain C Hydrogen bonds: B:Y.32, C:H.27, C:Q.31 Water bridges: B:L.101

1 x 144: TRIS-HYDROXYMETHYL-METHYL-AMMONIUM(Non-covalent)

144.8: 8 residues within 4Å: Chain B: Y.150, E.153, P.154, V.155, F.171, P.172, A.173, L.183 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:Y.150, B:E.153, B:V.155, B:A.173 Salt bridges: B:E.153

2 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)

PGE.9: 10 residues within 4Å: Chain A: Q.38, G.41, Q.42 Chain B: A.9, V.93, F.95, Q.110, G.111, T.112, T.113 7 PLIP interactions: 5 interactions with chain B, 2 interactions with chain A Hydrogen bonds: B:T.113, B:T.113, A:Q.42 Water bridges: B:S.7, B:A.9, B:G.111, A:G.41 PGE.10: 2 residues within 4Å: Chain B: E.10, S.17 1 PLIP interactions: 1 interactions with chain B Water bridges: B:S.17

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Subas Satish, H.P. et al., A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cells. Cell Death Differ. (2024)

Release Date

2024-04-10

Peptides

14G6 Fab light chain: A
14G6 Fab heavy chain: B
Bcl-2 homologous antagonist/killer: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
L

B
H

C
C

14G6 Fab light chain

14G6 Fab heavy chain

Bcl-2 homologous antagonist/killer

Related Entries With Identical Sequence